Evidence map›Paper›PMID 15726402›Full record

ArticleVirchows Archiv : an international journal of pathology2005

Simultaneous tumour-like, atypical basal cell hyperplasia and acinar adenocarcinoma of the prostate: a comparative morphological and genetic approach.

A M Luebke, T Schlomm, B Gunawan, H Bonkhoff, L Füzesi, A Erbersdobler

Abstract readCase ReportsComparative Study
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Genomic Characterization of Prostatic Basal Cell Carcinoma.The American journal of pathology · 2023
    Article
  2. Article
  3. The benign mimickers of prostatic acinar adenocarcinoma.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2016
    Review
  4. Review
  5. Basaloid adenocarcinoma. A new variant of pulmonary adenocarcinoma.Virchows Archiv : an international journal of pathology · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

A M LuebkeDepartment of Urology, University of Hamburg, Martinistrasse 52, 22081 Hamburg, Germany.
T Schlomm
B Gunawan
H Bonkhoff
L Füzesi
A Erbersdobler
Universität Hamburg · DEUniversity of Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Basal cell tumours of the prostatic gland are rare, and the classification is difficult. In the present case report, a large, tumour-like proliferation of atypical basaloid cells was found incidentally in a prostatectomy specimen that otherwise contained a conventional acinar adenocarcinoma. The basaloid cells displayed a solid or adenoid-cystic growth pattern and strongly expressed high-molecular-weight cytokeratins and bcl-2. A high Ki-67 index was recorded within the atypical basaloid cells, by far exceeding the one counted in the conventional adenocarcinoma. However, there were no definite criteria for a malignant behaviour of the basal cell tumour. Comparative genomic hybridisation from microdissected tumour cells yielded losses at the short arms of chromosomes 8 and 12 in the conventional adenocarcinoma and a normal karyotype in the basal cell tumour. The pathological findings favoured the diagnosis of an atypical basal cell hyperplasia.

Indexed as

Carcinoma, Acinar CellDiagnosis, DifferentialHumansImmunohistochemistryMaleMiddle AgedNeoplasms, Basal CellNucleic Acid HybridizationProstatic HyperplasiaProstatic Neoplasms

Identifiers

PMID15726402
OpenAlexW2089721023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.